Research study Program year 2023 Source: CMS Open Payments

Lnf-011

ClinicalTrials.gov NCT03719313

Research payments

$30,140

10 payments

Through program year 2023, $30,140 in research payments was reported against Lnf-011, across 10 payments, paid by Eiger BioPharmaceuticals, Inc..

Paid by: Eiger BioPharmaceuticals, Inc.
ClinicalTrials.gov: NCT03719313

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$2,400	1
2022	Research	$9,640	3
2021	Research	$18,100	6

Breakdown

Who paid Research payments · program years 2021–2023

Eiger BioPharmaceuticals, Inc. $30,140 10 payments

Who received the money Research payments · program years 2021–2023

Michael Charlton MD Organisation paid for research $14,040 3 payments
Adrian Dibisceglie Gastroenterology · Saint Louis, MO $10,900 5 payments
Adrian Di Bisceglie Organisation paid for research $2,800 1 payment
1 Organisation paid for research $2,400 1 payment

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program years 2021–2023

Professional salary support $30,140 10 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.